{"file_path": "/Users/sz904/Desktop/11711/LTI_Neural_Navigator/data/2024-02-26/chunk_paper_txt/Shinji_Watanabe_Antiviral_Susceptibilities_of_Distinct_Lineages_of_Influenza_C_and_D_Viruses_chunk_6.txt", "num_qa_pairs": 10, "qa_list": [{"question": " What is the title of the article referenced in the text?,answer: In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " According to the text, when was a novel swine influenza virus isolated from Oklahoma?,answer: 2011", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " What is the name of the cap-dependent endonuclease inhibitor mentioned in the text?,answer: baloxavir", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " Which country reported the detection of influenza A(H3N2) viruses with reduced susceptibility to baloxavir in December 2018?,answer: Japan", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " What is the impact of treatment-emergent influenza variant viruses with reduced baloxavir susceptibility on clinical and virologic outcomes in uncomplicated influenza?,answer: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " In which country was a study conducted on Baloxavir Marboxil in Japanese pediatric patients with influenza?,answer: Japan", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " What is the mechanism of resistance to favipiravir in influenza?,answer: Not provided in the text.", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " What is the potential threat mentioned in the text related to Influenza D Virus?,answer: Emerging Influenza D Virus Threat", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " What is the topic of the article that discusses the survival of influenza virus between epidemics and antigenic variants of the virus?,answer: Studies on Survival of Influenza Virus Between Epidemics and Antigenic Variants of the Virus", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}, {"question": " Where was Influenza D Virus detected among swine and cattle according to the text?,answer: Italy", "ref_chunk": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}], "doc_text": "In Vitro Ef\ufb01cacy of Antiviral Agents against Omicron Subvariant BA.4.6. N. Engl. J. Med. 2022, 387, 2094\u20132097. [CrossRef] 23. Hause, B.M.; Ducatez, M.; Collin, E.A.; Ran, Z.; Liu, R.; Sheng, Z.; Armien, A.; Kaplan, B.; Chakravarty, S.; Hoppe, A.D.; et al. Isolation of a Novel Swine In\ufb02uenza Virus from Oklahoma in 2011 Which Is Distantly Related to Human In\ufb02uenza C Viruses. PLoS Pathog. 2013, 9, e1003176. [CrossRef] 24. Murakami, S.; Sato, R.; Ishida, H.; Katayama, M.; Takenaka-Uema, A.; Horimoto, T. In\ufb02uenza D Virus of New Phylogenetic Lineage, Japan. Emerg. Infect. Dis. 2020, 26, 168\u2013171. [CrossRef] 25. Takashita, E.; Kawakami, C.; Morita, H.; Ogawa, R.; Fujisaki, S.; Shirakura, M.; Miura, H.; Nakamura, K.; Kishida, N.; Kuwahara, T.; et al. Detection of in\ufb02uenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Eurosurveillance 2019, 24, 1800698. [CrossRef] 26. Takashita, E.; Abe, T.; Morita, H.; Nagata, S.; Fujisaki, S.; Miura, H.; Shirakura, M.; Kishida, N.; Nakamura, K.; Kuwahara, T.; et al. In\ufb02uenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatment. Antivir. Res. 2020, 180, 104828. [CrossRef] Sugawara, K.; Nishimura, H.; Hongo, S.; Kitame, F.; Nakamura, K. Antigenic Characterization of the Nucleoprotein and Matrix Protein of In\ufb02uenza C Virus with Monoclonal Antibodies. J. Gen. Virol. 1991, 72, 103\u2013109. [CrossRef] Ishida, H.; Murakami, S.; Kamiki, H.; Matsugo, H.; Takenaka-Uema, A.; Horimoto, T. Establishment of a Reverse Genetics System for In\ufb02uenza D Virus. J. Virol. 2020, 94, e01767-19. [CrossRef] 27. 28. 29. Zhang, Y.; Aevermann, B.D.; Anderson, T.K.; Burke, D.F.; Dauphin, G.; Gu, Z.; He, S.; Kumar, S.; Larsen, C.N.; Lee, A.J.; et al. In\ufb02uenza Research Database: An integrated bioinformatics resource for in\ufb02uenza virus research. Nucleic Acids Res. 2016, 45, D466\u2013D474. [CrossRef] 30. Noshi, T.; Kitano, M.; Taniguchi, K.; Yamamoto, A.; Omoto, S.; Baba, K.; Hashimoto, T.; Ishida, K.; Kushima, Y.; Hattori, K.; et al. In vitro characterization of baloxavir acid, a \ufb01rst-in-class cap-dependent endonuclease inhibitor of the in\ufb02uenza virus polymerase PA subunit. Antivir. Res. 2018, 160, 109\u2013117. [CrossRef] 31. Uehara, T.; Hayden, F.G.; Kawaguchi, K.; Omoto, S.; Hurt, A.C.; De Jong, M.D.; Hirotsu, N.; Sugaya, N.; Lee, N.; Baba, K.; et al. Treatment-Emergent In\ufb02uenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated In\ufb02uenza. J. Infect. Dis. 2019, 221, 346\u2013355. [CrossRef] 32. Hirotsu, N.; Sakaguchi, H.; Sato, C.; Ishibashi, T.; Baba, K.; Omoto, S.; Shishido, T.; Tsuchiya, K.; Hayden, F.G.; Uehara, T.; et al. Baloxavir Marboxil in Japanese Pediatric Patients With In\ufb02uenza: Safety and Clinical and Virologic Outcomes. Clin. Infect. Dis. 2019, 71, 971\u2013981. [CrossRef] [PubMed] 33. Hayden, F.G.; Sugaya, N.; Hirotsu, N.; Lee, N.; De Jong, M.D.; Hurt, A.C.; Ishida, T.; Sekino, H.; Yamada, K.; Portsmouth, S.; et al. Baloxavir Marboxil for Uncomplicated In\ufb02uenza in Adults and Adolescents. N. Engl. J. Med. 2018, 379, 913\u2013923. [CrossRef] [PubMed] 34. Goldhill, D.H.; te Velthuis, A.J.W.; Fletcher, R.A.; Langat, P.; Zambon, M.; Lackenby, A.; Barclay, W.S. The mechanism of resistance to favipiravir in in\ufb02uenza. Proc. Natl. Acad. Sci. USA 2018, 115, 11613\u201311618. [CrossRef] [PubMed] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 35. Asha, K.; Kumar, B. Emerging In\ufb02uenza D Virus Threat: What We Know so Far! J. Clin. Med. 2019, 8, 192. [CrossRef] 36. Taylor, R.M. Studies on Survival of In\ufb02uenza Virus Between Epidemics and Antigenic Variants of the Virus. Am. J. Public Health Nations Health 1949, 39, 171\u2013178. [CrossRef] Sreenivasan, C.C.; Sheng, Z.; Wang, D.; Li, F. Host Range, Biology, and Species Speci\ufb01city of Seven-Segmented In\ufb02uenza Viruses\u2014A Comparative Review on In\ufb02uenza C and D. Pathogens 2021, 10, 1583. [CrossRef] 38. Matsuzaki, Y.; Katsushima, N.; Nagai, Y.; Shoji, M.; Itagaki, T.; Sakamoto, M.; Kitaoka, S.; Mizuta, K.; Nishimura, H. Clinical Features of In\ufb02uenza C Virus Infection in Children. J. Infect. Dis. 2006, 193, 1229\u20131235. [CrossRef] 39. Odagiri, T.; Matsuzaki, Y.; Okamoto, M.; Suzuki, A.; Saito, M.; Tamaki, R.; Lupisan, S.P.; Sombrero, L.T.; Hongo, S.; Oshitani, H. Isolation and Characterization of In\ufb02uenza C Viruses in the Philippines and Japan. J. Clin. Microbiol. 2015, 53, 847\u2013858. [CrossRef] Shimizu, Y.; Abiko, C.; Ikeda, T.; Mizuta, K.; Matsuzaki, Y. In\ufb02uenza C Virus and Human Metapneumovirus Infections in Hospitalized Children With Lower Respiratory Tract Illness. Pediatr. Infect. Dis. J. 2015, 34, 1273\u20131275. [CrossRef] 40. 41. Gouarin, S.; Vabret, A.; Dina, J.; Petitjean, J.; Brouard, J.; Cuvillon-Nimal, D.; Freymuth, F. Study of in\ufb02uenza C virus infection in France. J. Med. Virol. 2008, 80, 1441\u20131446. [CrossRef] 42. Thielen, B.K.; Friedlander, H.; Bistodeau, S.; Shu, B.; Lynch, B.; Martin, K.; Bye, E.; Como-Sabetti, K.; Boxrud, D.; Strain, A.K.; et al. Detection of In\ufb02uenza C Viruses Among Outpatients and Patients Hospitalized for Severe Acute Respiratory Infection, Minnesota, 2013\u20132016. Clin. Infect. Dis. 2017, 66, 1092\u20131098. [CrossRef] [PubMed] 9 of 10 Viruses 2023, 15, 244 43. Ducatez, M.F.; Pelletier, C.; Meyer, G. In\ufb02uenza D Virus in Cattle, France, 2011\u20132014. Emerg. Infect. Dis. 2015, 21, 368\u2013371. [CrossRef] [PubMed] 44. Chiapponi, C.; Faccini, S.; De Mattia, A.; Baioni, L.; Barbieri, I.; Rosignoli, C.; Nigrelli, A.; Foni, E. Detection of In\ufb02uenza D Virus among Swine and Cattle, Italy. Emerg. Infect. Dis. 2016, 22, 352\u2013354. [CrossRef] [PubMed] 45. Mitra, N.; Cernicchiaro, N.; Torres, S.; Li, F.; Hause, B.M. Metagenomic characterization of the virome associated with bovine respiratory disease in feedlot cattle identi\ufb01ed novel viruses and suggests an etiologic role for in\ufb02uenza D virus. J. Gen. Virol. 2016, 97, 1771\u20131784. [CrossRef] [PubMed] 46. Horimoto, T.; Hiono, T.; Mekata, H.; Odagiri, T.; Lei, Z.; Kobayashi, T.; Norimine, J.; Inoshima, Y.; Hikono, H.; Murakami, K.; et al. Nationwide Distribution of Bovine In\ufb02uenza D Virus Infection in Japan. PLoS ONE"}